Warning
This is an unofficial archive of PsychonautWiki as of 2025-08-11T15:14:44Z. Content on this page may be outdated, incomplete, or inaccurate. Please refer to the original page for the most up-to-date information.

Template:SubstanceBox/Example: Difference between revisions

From PsychonautWiki Archive
Jump to navigation Jump to search
← Older editNewer edit →
>Unity
Adjust RoA displays.
>Unity
Update caption. Remove example citation.
Line 33: Line 33:


     <!-- Structure -->
     <!-- Structure -->
     |MolecularStructureCaption=Skeletal structure of a Dimethyltryptamine molecule
     |MolecularStructureCaption=Molecular structure of DMT molecule
     |SkeletalImageFile=File:DMT.svg
     |SkeletalImageFile=File:DMT.svg
     |SkeletalImageWidth=245px
     |SkeletalImageWidth=245px
Line 46: Line 46:
     <!-- Class Membership -->
     <!-- Class Membership -->
     |EffectClass=[[psychoactive class::Psychedelic]]
     |EffectClass=[[psychoactive class::Psychedelic]]
     |ChemicalClass=[[chemical class::Lysergamide]]
     |ChemicalClass=[[chemical class::Tryptamine]]


     <!-- Dosage/Duration per ROA -->
     <!-- Dosage/Duration per ROA -->
Line 72: Line 72:
     |SublingualROA_Collapsed=false
     |SublingualROA_Collapsed=false
     |SublingualROA_Caption=
     |SublingualROA_Caption=
     |SublingualROA_Bioavailability=[[Sublingual min bioavailability::x1]]% - [[Sublingual max bioavailability::x2]]%<ref>Dolder, P. C., Schmid, Y., Haschke, M., Rentsch, K. M., & Liechti, M. E. (2016). Pharmacokinetics and concentration-effect relationship of oral LSD in humans. International Journal of Neuropsychopharmacology, 19(1), 1–7. https://doi.org/10.1093/ijnp/pyv072</ref>
     |SublingualROA_Bioavailability=[[Sublingual min bioavailability::x1]]% - [[Sublingual max bioavailability::x2]]%
     |SublingualROA_Microdose=
     |SublingualROA_Microdose=
     |SublingualROA_Threshold=[[Sublingual threshold dose::x1]] - [[Sublingual dose units::mg]]  
     |SublingualROA_Threshold=[[Sublingual threshold dose::x1]] - [[Sublingual dose units::mg]]  

Revision as of 21:20, 24 January 2018

SubstanceBox/Example
Chemical Nomenclature
Common names DMT
Substitutive name N,N-Dimethyltryptamine
Systematic name 2-(1H-Indol-3-yl)-N,N-dimethylethanamine
Class Membership
Psychoactive class Psychedelic
Chemical class Tryptamine
Routes of Administration

WARNING: Always start with lower doses due to differences between individual body weight, tolerance, metabolism, and personal sensitivity. See responsible use section.



⇣ Oral
Dosage
Bioavailability x1% - x2%[1]
Threshold x - mg
Light x1 - x2 mg
Common x1 - x2 mg
Strong x1 - x2 mg
Heavy x mg +
Duration
Total x1 - x2 hours
Onset x1 - x2 minutes
Come up x1 - x2 minutes
Peak x1 - x2 hours
Offset x1 - x2 hours
After effects x1 - x2 hours


⇣ Sublingual
Dosage
Bioavailability x1% - x2%
Threshold x1 - mg
Light x1 - x2 mg
Common x1 - x2 mg
Strong x1 - x2 mg
Heavy x1 mg +
Duration
Total 8 - 12 hours
Onset 15 - 30 minutes
Come up 45 - 90 minutes
Peak 4 - 6 hours
Offset 3 - 4 hours
After effects 12 - 48 hours







DISCLAIMER: PW's dosage information is gathered from users and resources for educational purposes only. It is not a recommendation and should be verified with other sources for accuracy.

  1. ↑ APA formatted citation
Retrieved from "http://psy.st/w/index.php?title=Template:SubstanceBox/Example&oldid=99597"